TY  - JOUR
AU  - Roche, Bruno
AU  - Bauhofer, Artur
AU  - Gomez Bravo, Miguel Ãngel
AU  - Pageaux, Georges Philippe
AU  - Zoulim, Fabien
AU  - Otero, Alejandra
AU  - Prieto, Martin
AU  - Baliellas, Carmen
AU  - Samuel, Didier
PY  - 2022
DO  - 10.12659/AOT.936162
UR  - http://hdl.handle.net/10668/21680
T2  - Annals of transplantation
AB  - BACKGROUND Self-administered subcutaneous hepatitis B immunoglobulin (s.c. HBIg) in combination with nucleos(t)ide analogs (NUCs) has proved to be effective and safe in preventing hepatitis B virus (HBV) reinfection after liver transplantation....
LA  - en
KW  - Adult
KW  - Antiviral Agents
KW  - Carcinoma, Hepatocellular
KW  - Female
KW  - Hepatitis B
KW  - Humans
KW  - Immunoglobulins
KW  - Liver Neoplasms
KW  - Liver Transplantation
KW  - Male
KW  - Neoplasm Recurrence, Local
KW  - Patient Reported Outcome Measures
KW  - Prospective Studies
KW  - Quality of Life
KW  - Recurrence
KW  - Reinfection
KW  - Treatment Outcome
TI  - Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study.
TY  - research article
VL  - 27
ER  -